Pfizer Inc. (BCBA:PFE)

Argentina flag Argentina · Delayed Price · Currency is ARS
10,150
+120 (1.20%)
Feb 10, 2026, 4:59 PM BRT
Market Cap220.76T +42.6%
Revenue (ttm)90.83T -1.6%
Net Income11.28T -3.2%
EPS1,980.25 -3.4%
Shares Outn/a
PE Ratio19.57
Forward PE9.27
Dividend421.12 (4.25%)
Ex-Dividend DateJan 23, 2026
Volume22,986
Average Volume35,144
Open10,040
Previous Close10,030
Day's Range9,870 - 10,180
52-Week Range5,990 - 10,800
Beta0.43
RSI52.11
Earnings DateFeb 3, 2026

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr... [Read more]

Sector Healthcare
Founded 1849
Employees 81,000
Stock Exchange Buenos Aires Stock Exchange
Ticker Symbol PFE
Full Company Profile

Financial Performance

In 2025, Pfizer's revenue was $62.58 billion, a decrease of -1.65% compared to the previous year's $63.63 billion. Earnings were $7.77 billion, a decrease of -3.24%.

Financial numbers in USD Financial Statements